News
Patients Find Weight Loss Drug Zepbound A Game Changer, But Makers See Production Delay Until 2025
18 Apr 24
Biotech, Large Cap, News, Health Care, General
Here's How Much You Would Have Made Owning Eli Lilly and Co Stock In The Last 15 Years
18 Apr 24
News, Trading Ideas
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $815 Price Target
18 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Eli Lilly and Co's Options Frenzy: What You Need to Know
17 Apr 24
Options, Markets
Eli Lilly's Famed Weight Loss Drug Zepbound Works As Sleep Apnea Treatment, Successful Late-Stage Studies Show
17 Apr 24
Biotech, Large Cap, News, Health Care, Movers, Trading Ideas, General
Avalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgrades
16 Apr 24
Analyst Color, Biotech, Equities, News, Upgrades, Health Care, Price Target, Analyst Ratings, Movers, Trading Ideas, General
Cantor Fitzgerald Reiterates Overweight on Eli Lilly and Co, Maintains $815 Price Target
15 Apr 24
News, Price Target, Reiteration, Analyst Ratings
Novo Nordisk's Dominance In Obesity & Diabetes Drug Market Backed by Strong Pipeline: Analyst Gives Outperform Rating
12 Apr 24
Trading Ideas
Eli Lilly Suffers Legal Loss For Its Popular Weight Loss/Diabetes Drug In Lawsuit Against Florida Compounding Pharmacy
12 Apr 24
Biotech, Large Cap, News, Health Care, Legal, General
Novo Nordisk/Eli Lilly's Weight Loss Drugs Does Not Cause Suicidal Behaviors - After FDA, European Medicines Agency Says
12 Apr 24
Biotech, Large Cap, News, Health Care, Top Stories, Movers, General
Pharmacovigilance Risk Assessment Committee Clears GLP-1 Diabetes Medications of Causing Suicidal or Self-Injurious Behavior
12 Apr 24
Government, News, Regulations
Goldman Sachs Maintains Neutral on Eli Lilly and Co, Raises Price Target to $723
11 Apr 24
News, Price Target, Analyst Ratings
Amphastar Pharmaceuticals Interested In Potential Acquisitions In Endocrinology-Focused Companies
10 Apr 24
Analyst Color, Biotech, News, Health Care, Analyst Ratings, Trading Ideas, General
Jim Cramer Stands By Nvidia And Eli Lilly Despite Market Dips, Says 'Terrific Time To Take Some Profits'
9 Apr 24
Equities, News, Markets, Tech
10 Health Care Stocks With Whale Alerts In Today's Session
9 Apr 24
Options
Eli Lilly and Co's Options: A Look at What the Big Money is Thinking
9 Apr 24
Options, Markets
ProfoundBio Discovers The Joys Of Having A Wealthy Owner
8 Apr 24
Penny Stocks, Small Cap, Markets
Traders Rethink Interest Rate Cuts, Labor Market Heats Up, Oil Prices Quietly Reach 6-Month High: This Week In The Markets
5 Apr 24
Equities, Large Cap, Macro Economic Events, Sector ETFs, Commodities, Econ #s, Top Stories, Economics, Federal Reserve, Tech, ETFs
Wondering Where To Find An Over 7% Annual Return? Check Out These 10 Investment-Grade Corporate Bonds
5 Apr 24
Large Cap, Mid Cap, REIT, Bonds, Small Cap, Econ #s, Top Stories, Real Estate
Understanding Eli Lilly and Co's Position In Pharmaceuticals Industry Compared To Competitors
5 Apr 24
News, Markets, Trading Ideas
Press releases
Navigating Interest Rate Speculations and M&A Trends with a Spotlight on Actinium Pharmaceuticals (ATNM)
18 Apr 24
News, Press Releases
Tirzepatide reduced sleep apnea severity by up to nearly two-thirds in adults with obstructive sleep apnea (OSA) and obesity
17 Apr 24
Press Releases
Lilly Confirms Date and Conference Call for First-Quarter 2024 Financial Results Announcement
16 Apr 24
Press Releases
Thinking about trading options or stock in Intuit, Pinterest, Adobe, Eli Lilly, or Robinhood Markets?
14 Mar 24
Opinion, Press Releases
More than two-thirds of people with atopic dermatitis and skin of color experienced skin improvement in a first-of-its-kind lebrikizumab study
10 Mar 24
Press Releases
U.S. Food and Drug Administration to Convene Advisory Committee Meeting to Discuss the TRAILBLAZER-ALZ 2 Study of Donanemab
8 Mar 24
Press Releases
Thinking about buying stock in SoundHound AI, Eli Lilly, Dell Technologies, NKGen Biotech, or Riot Platforms?
6 Mar 24
Small Cap, Opinion, Press Releases
Lilly Announces Details of Presentations at 2024 American Association for Cancer Research (AACR) Annual Meeting
5 Mar 24
Press Releases
Better Therapeutics Follows Up Wins Including FDA Authorization For AspyreRx In 2023 With Securing FDA Breakthrough Device Designation Targeting Advanced Liver Disease
26 Feb 24
Lilly to Participate in Cowen's 44th Annual Health Care Conference
20 Feb 24
Press Releases
Global Fibromyalgia Treatment Market Expected to Reach $4.6 billion by 2032
15 Feb 24
Press Releases
Thinking about trading options or stock in Amazon, Eli Lilly, Altimmune, Novavax, or Snap?
12 Feb 24
Opinion, Press Releases
Philip Johnson to Retire as Lilly Treasurer
9 Feb 24
Press Releases
Thinking about buying stock in Foghorn Therapeutics, Oscar Health, Eli Lilly And Co, Palo Alto Networks, or CN ENERGY GROUP?
8 Feb 24
Small Cap, Opinion, Press Releases
Lilly Reports Strong Fourth-Quarter 2023 Financial Results and Provides 2024 Guidance
6 Feb 24
Earnings, Press Releases
Thinking about trading options or stock in General Motors, Meta Platforms, Archer-Daniels-Midland, Eli Lilly, or Celestica?
30 Jan 24
Opinion, Press Releases
Thinking about trading options or stock in Tesla, Amazon, Microsoft, Eli Lilly, or Halliburton?
26 Jan 24
Opinion, Press Releases
Johna Norton to Retire as Lilly Executive Vice President of Global Quality
25 Jan 24
Press Releases
Positive Phase 1/2 Clinical Trial Data for an Investigational Gene Therapy for Genetic Hearing Loss to be Presented at the Association for Research in Otolaryngology 2024 MidWinter Meeting
23 Jan 24
Press Releases
Lilly Confirms Date and Conference Call for Fourth-Quarter 2023 Financial Results and 2024 Financial Guidance
23 Jan 24
Press Releases